Home » Topics » Addiction »
An interdisciplinary panel formulated recommendations on opioid tapering strategies in primary care, with particular emphasis placed on addressing biopsychosocial perspectives.
Given the rising numbers of opioid use among women, researchers sought to provide a review of opioid use disorder in women and the implications for treatment.
Reporting on three cases of successful transition from low dose sublingual buprenorphine to a single injection of 100 mg extended release buprenorphine.
Adolescent sleep deficiency as an increased future risk for prescription opioid misuse was examined in a large nationally, representative database designed to track health behaviors and outcomes from adolescence to early adulthood.
Opioid products approved by the FDA between 1997 and 2018 relied on short- or intermediate-term studies that did not adequately analyze safety outcomes.
Investigators revealed distinct neuronal and non-neuronal epigenetic signatures and identified a locus in the proximity of the gene encoding tyrosine kinase FYN as the most affected region in neurons.
Adults with chronic back pain who had adverse allergic reactions to NSAIDs are at higher risk for developing an opioid use disorder.
Benzodiazepines are widely used to treat a variety of conditions including anxiety disorders, insomnia and seizures.
Pregnancy and insurance status were significant barriers to obtaining appointments for opioid use disorder treatment.
Burnout is on the rise among psychiatrists. Explore the driving factors behind this trend and learn key interventions to avoid its negative effects.
The Targeting Effective Analgesia in Clinics for HIV intervention is a promising strategy for improving adherence to opioid prescribing guidelines among HIV care providers and their patients on chronic opioid therapy.
Want to read more?
Please login or register first to view this content.
Next post in Opioid-Related Disorder